A Study of the Efficacy and Safety of MEDI7352 in Participants With Painful Osteoarthritis of the Knee

PHASE2CompletedINTERVENTIONAL
Enrollment

345

Participants

Timeline

Start Date

December 2, 2020

Primary Completion Date

August 16, 2023

Study Completion Date

August 16, 2023

Conditions
Painful Osteoarthritis of the Knee
Interventions
DRUG

MEDI7352

Participants will receive SC injection of MEDI7352 as stated in arm description.

OTHER

Placebo

Participants will receive SC injection of placebo as stated in arm description.

Trial Locations (41)

2000

Research Site, Frederiksberg

10117

Research Site, Tallinn

15006

Research Site, A Coruña

15702

Research Site, Santiago de Compostela

15705

Research Site, Santiago de Compostela

15706

Research Site, Santiago de Compostela-Coruña

18209

Research Site, Bad Doberan

28034

Research Site, Madrid

29010

Research Site, Málaga

46010

Research Site, Valencia

50708

Research Site, Tartu

80809

Research Site, Munich

04107

Research Site, Leipzig

15-351

Research Site, Bialystok

15-897

Research Site, Bialystok

85-065

Research Site, Bydgoszcz

82-300

Research Site, Elblag

81-338

Research Site, Gdynia

90-302

Research Site, Lodz

20-607

Research Site, Lublin

61-113

Research Site, Poznan

24-100

Research Site, Puławy

28-200

Research Site, Staszów

87-100

Research Site, Torun

00-874

Research Site, Warsaw

22-400

Research Site, Zamość

08035

Research Site, Barcelona

08208

Research Site, Sabadell

NN18 9EZ

Research Site, Corby

EN3 4GS

Research Site, Enfield

G51 4TF

Research Site, Glasgow

HP11 2QW

Research Site, High Wycombe

LS7 4SA

Research Site, Leeds

EC2Y 8EA

Research Site, London

CW9 7LS

Research Site, Northwich

HA6 2RN

Research Site, Northwood

BR5 3QG

Research Site, Orpington

PR2 9QB

Research Site, Preston

OL11 4AU

Research Site, Rochdale

M6 8HD

Research Site, Salford

BD18 3SA

Research Site, Shipley

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY